Illustration of a child exhaling dust mites, representing allergy relief.

Breathe Easier: How Immunotherapy Can Help Kids with Allergies & Asthma

Lena Voss monogram
Lena Voss in Health & Wellness October 2026 • 4 min read.

"Is your child struggling with allergic rhinitis and asthma? Discover how subcutaneous immunotherapy (SCIT) can provide lasting relief, regardless of specific allergen sensitivities."


Allergic rhinitis (AR) and asthma are common chronic conditions that significantly impact the quality of life for millions of children and their families. These conditions often stem from sensitivities to common allergens, such as house dust mites. In many tropical climates, two dominant house dust mites, Dermatophagoides pteronyssinus (DP) and Blomia tropicalis (BT), are major culprits.

For children struggling with allergies and asthma, finding effective, long-term solutions is essential. While avoidance measures and medications can provide some relief, they don't address the underlying cause of the allergic reaction. Allergen immunotherapy (AIT) offers a promising approach by gradually desensitizing the immune system to specific allergens, leading to reduced symptoms and medication needs.

AIT, specifically Subcutaneous Immunotherapy (SCIT) using Dermatophagoides pteronyssinus (DP), has emerged as a valuable treatment option. A recent study delved into the effectiveness of DP-SCIT in children with allergic rhinitis and asthma, irrespective of whether they were also sensitive to Blomia tropicalis (BT). Let's explore the key findings and what they mean for families seeking allergy relief.

AI Search Multiple angles on this topic

Allergies and Everyday Impact

Allergy is a hypersensitivity reaction to foreign substances that may be harmless to other people in similar amounts and circumstances. Dust mite allergy, also called house dust allergy, involves sensitization and an allergic reaction to dust-mite droppings. It can trigger reactions such as asthma, eczema, or itching.

Seasonal Allergy Patterns

Seasonal allergies are usually caused by pollen from trees, grasses, and weeds. WebMD reports that most trees release pollen in spring, followed by grasses. This seasonal pattern can help explain why symptoms recur at similar times each year, although the source does not establish that pollen is the cause of every allergy.

A Developing Understanding

The understanding of allergies has developed through efforts to explain why some bodies react strongly to otherwise harmless substances. In the context of children with allergies and asthma, this perspective supports continued interest in treatments that address underlying sensitivity rather than symptoms alone. The historical record and milestones are not detailed in the supplied material, so any broader account should be treated as general context.

Understanding Subcutaneous Immunotherapy (SCIT) and Its Benefits for Allergic Children

Illustration of a child exhaling dust mites, representing allergy relief.

Subcutaneous immunotherapy (SCIT) involves administering gradually increasing doses of an allergen extract through injections. This process helps the immune system become less reactive to the allergen over time, reducing the severity of allergic reactions. SCIT is a disease-modifying treatment, meaning it aims to change the course of the allergic condition, rather than just managing the symptoms.

One of the primary ways SCIT works is by increasing the production of allergen-specific IgG4 antibodies. These antibodies act as "blocking antibodies," competing with IgE antibodies (the ones responsible for triggering allergic reactions) for allergen binding. By reducing the amount of allergen that can bind to IgE, SCIT helps to minimize allergic symptoms.

  • Reduced Symptoms: SCIT can significantly decrease the frequency and severity of allergy symptoms like sneezing, runny nose, itchy eyes, coughing, and wheezing.
  • Lower Medication Needs: As SCIT desensitizes the immune system, many individuals can reduce their reliance on antihistamines, nasal sprays, and asthma inhalers.
  • Improved Quality of Life: By alleviating allergy symptoms and decreasing medication dependence, SCIT can lead to better sleep, increased energy levels, and greater participation in daily activities.
  • Long-Term Relief: SCIT offers the potential for long-lasting relief, even after treatment is discontinued. Some studies have shown that the benefits of SCIT can persist for years.
AI Search Multiple angles on this topic

Evidence Continues to Evolve

Research on immunotherapy for children with allergies and asthma continues to evolve, but no specific studies or reviews were supplied for this subsection. The available material therefore does not support naming a particular finding, product, or outcome. Claims about the latest evidence should be checked against current clinical research and reviews.

Limits and Uncertainty

Immunotherapy may not produce identical results for every child, and treatment decisions require attention to individual circumstances. However, the supplied material does not identify particular failures, adverse outcomes, or counterarguments. Those issues should therefore be discussed cautiously rather than assigned unsupported rates or conclusions.

Choosing Among Approaches

Comparing immunotherapy with other allergy or asthma approaches requires evidence about effectiveness, safety, duration, and practical burden. No comparative studies or source-specific findings were supplied here. A responsible comparison should therefore avoid declaring one option universally superior.

The study aimed to determine whether DP-SCIT benefits children with allergic asthma and rhinitis who are exposed to and sensitized to both DP and BT. Researchers also investigated whether DP-SCIT-induced allergen-specific IgG4 antibodies cross-react with BT antigens.

Empowering Families with Knowledge and Options

These findings offer hope for children with allergic rhinitis and asthma, demonstrating that DP-SCIT can be effective even when sensitivities to multiple allergens like DP and BT exist. If your child is struggling with allergies, talk to their doctor about whether SCIT is the right option. With proper diagnosis and a tailored treatment plan, your child can breathe easier and enjoy a healthier, more active life.

AI Search Multiple angles on this topic

Putting Treatment in Context

Immunotherapy is best considered within a broader plan for managing a child's allergic disease and respiratory symptoms. The supplied material does not include expert quotations or treatment-specific recommendations for synthesis. Families should rely on individualized guidance from qualified healthcare professionals.

Looking Ahead

Future work may clarify how immunotherapy can be tailored for children with allergies and asthma. The supplied material does not identify specific emerging technologies, trials, or projected milestones. Any forecast should therefore remain tentative until supported by current research.

Access and Environment

Allergy management can be shaped by environmental exposures, healthcare access, and the ability of families to follow treatment plans. No source was supplied describing specific systemic barriers or disparities for this subsection. These challenges should be acknowledged without assigning unsupported prevalence figures.

Living With Allergies

For children and families, allergies can affect daily comfort and contribute to concerns about asthma, eczema, or itching. Treatment choices also involve practical questions about routines, monitoring, and family preferences. The supplied material does not provide patient accounts or measured quality-of-life outcomes, so these effects should be described as potential experiences rather than quantified results.

What the asthma results suggest

The available evidence focuses on children with allergic asthma and objectively confirmed, clinically relevant sensitization to house dust mites. It does not by itself establish outcomes for children outside that group.[1]

How pediatric asthma findings compare

A pediatric review included trials of both injected and under-the-tongue immunotherapy, alongside non-randomized studies assessing safety. Its symptom-score findings are difficult to interpret as definitive because the review found no trials using a validated asthma-symptom measure.[2]

The evidence describes immunotherapy alongside allergen avoidance and medication as treatment options for allergic asthma. It also notes that injections carry a risk of severe allergic reactions, a safety consideration distinct from symptom-score benefit.[2] [3]

What remains unresolved for injected immunotherapy

  • How durable are the benefits of injected immunotherapy for children with asthma? The evidence identifies long-term efficacy as an unresolved question.[1]
  • How well does injected immunotherapy work for children treated with mixtures of allergens or for those with severe asthma? The cited evidence specifically identifies these groups as needing clearer evaluation.[1]

Sources

  1. Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review (pmc.ncbi.nlm.nih.gov)
  2. Allergen-Specific Immunotherapy in the Treatment of Pediatric Asthma: A Systematic Review. (pubmed.ncbi.nlm.nih.gov)
  3. Allergen immunotherapy for the treatment of chronic asthma | Cochrane (www.cochrane.org)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is Subcutaneous Immunotherapy (SCIT), and how does it help children with allergies and asthma?

Subcutaneous Immunotherapy (SCIT) is a treatment that involves administering gradually increasing doses of an allergen extract through injections. This process aims to desensitize the immune system to specific allergens over time, thereby reducing the severity of allergic reactions. In children, SCIT can be particularly beneficial for managing allergic rhinitis and asthma. By increasing the production of allergen-specific IgG4 antibodies, SCIT acts by producing "blocking antibodies," which compete with IgE antibodies (the ones responsible for triggering allergic reactions) for allergen binding. This process helps to minimize allergic symptoms, potentially reducing the reliance on medications and improving the overall quality of life for children suffering from allergies and asthma.

2

How does SCIT specifically address allergies caused by Dermatophagoides pteronyssinus (DP) and Blomia tropicalis (BT) in children?

The article highlights the effectiveness of Dermatophagoides pteronyssinus (DP) - SCIT even in children sensitive to both DP and Blomia tropicalis (BT). While the study focuses on DP-SCIT, it acknowledges the prevalence of both allergens, especially in tropical climates. The research investigates whether the antibodies produced through DP-SCIT could provide some cross-reactivity or benefit for those sensitized to BT. SCIT aims to reduce the reactivity to DP, and the study explores the impact on individuals exposed to both DP and BT, offering a potential for broader allergy relief, even in the presence of multiple allergen sensitivities. This approach may offer some relief for those affected by BT, even if it isn't the primary target of the treatment.

3

What are the main benefits of SCIT for children dealing with allergic rhinitis and asthma?

The main benefits of Subcutaneous Immunotherapy (SCIT) for children with allergic rhinitis and asthma include: reduced allergy symptoms, lower medication needs, improved quality of life, and the potential for long-term relief. SCIT helps significantly decrease the frequency and severity of symptoms like sneezing, runny nose, itchy eyes, coughing, and wheezing. As the immune system becomes desensitized, the reliance on medications such as antihistamines, nasal sprays, and asthma inhalers may decrease. By alleviating symptoms and decreasing medication dependence, children can experience better sleep, higher energy levels, and increased participation in daily activities. Additionally, the benefits of SCIT can persist for years after the treatment is stopped.

4

How does SCIT work at a biological level to reduce allergy symptoms in children?

Subcutaneous Immunotherapy (SCIT) works by gradually introducing increasing doses of an allergen extract. This process aims to change the course of the allergic condition, rather than just managing symptoms. One of the primary mechanisms by which SCIT reduces allergy symptoms is by increasing the production of allergen-specific IgG4 antibodies. These IgG4 antibodies function as "blocking antibodies," competing with IgE antibodies, which are responsible for triggering allergic reactions, for allergen binding. By reducing the amount of allergen that can bind to IgE, SCIT helps to minimize the release of inflammatory substances, thereby lessening the severity of allergic symptoms such as sneezing, runny nose, itchy eyes, coughing, and wheezing. This targeted approach to modifying the immune response is the key to providing long-term relief from allergies and asthma.

5

What should parents do if they suspect their child might benefit from SCIT for allergies or asthma related to Dermatophagoides pteronyssinus (DP) or Blomia tropicalis (BT)?

If parents suspect their child is struggling with allergies or asthma, especially if linked to sensitivities to Dermatophagoides pteronyssinus (DP) or Blomia tropicalis (BT), they should first consult with their child's doctor. A proper diagnosis is crucial to determine if SCIT is the appropriate treatment option. The doctor will likely perform allergy testing to identify specific allergens causing the symptoms. If allergies to DP or other relevant allergens are confirmed, and if the child meets the criteria for SCIT, the doctor can then discuss a tailored treatment plan. This plan would include the administration of gradually increasing doses of the relevant allergen extracts through subcutaneous injections. Parents need to understand the treatment's potential benefits, risks, and the commitment required. With the right guidance and treatment plan, children can experience a significant improvement in their symptoms and overall quality of life.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.